Search Results - "M. I. Treshchalin"

Ascorbigen — Rifabutin Toxicity Modifier by Pereverzeva, E. R., Treshchalin, M. I., Treshchalin, I. D.

“…Relevance . Indications for rifabutin use are constantly expanding. It is used in the treatment of extremely complex nosological forms of infectious diseases…”
Get full text

Antitumor Activity and Toxicity of Olivamide Dosage Form, a New Semi-Synthetic Olivomycin a Derivative by Treshchalin, I. D., Treshchalin, M. I., Tevyashova, A. N., Pereverzeva, E. R.

“…Methods for selective chemical modification of the antibiotic olivomycin A (OA) were developed at G. F. Gause Institute of New Antibiotics. The compound with…”
Get full text

PROSPECTS FOR SEARCHING MULTITARGET TOPOISOMERASE INHIBITORS WITH ANTITUMOR PROPERTIES by Treshchalin, M. I., Neborak, E. V., Treshchalina, H. M.

“…Purpose of research : to identify the prospects of search for new antitumor non-camptothecin inhibitors of topoisomerase I/II among the various chemical…”
Get full text

Experimental Evaluation of Chronic Toxicity of Amphamide – a New Semisynthetic Derivative of Amphotericin B by Pereverzeva, E. R., Treshchalin, M. I., Bychkova, E. N., Tevyashova, A. N., Treshchalin, I. D.

“…Amphotericin B (AmB) remains a drug of first choice for treatment of most severe mycoses despite significant toxicity and solubility problems. Screening of a…”
Get full text

Preclinical Pharmacokinetics Study of Amphamide: a New Semisynthetic Antifungal Antibiotic by Portnoi, Yu. A., Kobrin, M. B., Dovzhenko, S. A., Tevyashova, A. N., Treshchalin, M. I., Golibrodo, V. A., Firsov, A. A.

“…The pharmacokinetics of amphamide, a new semisynthetic antifungal antibiotic, are studied after intravenous injection to rats and rabbits. The amphamide…”
Get full text

Preclinical Pharmacokinetic and Toxicity Studies of Anthrafuran – A New Antitumor Agent by Portnoi, Yu. A., Dovzhenko, S. A., Kobrin, M. B., Pereverzeva, E. R., Treshchalin, M. I., Golibrodo, V. A., Shchekotikhin, A. E., Firsov, A. A.

“…The pharmacokinetics and acute toxicity of the new anthra[2, 3- b ]furan-3-carboxamide derivative anthrafuran (AF) were studied after intravenous (i.v.),…”
Get full text

MODELING OF EX VIVO INTERNALIZATION METHOD OF WATER- SOLUBLE ANTICANCER DRUGS IN SMALL INTESTINE USING CHEMILUMINESCENCE by Treshalina, H. M., Andronova, N. V., Tcherkassova, J. R., Klinski, E. Yu, Babayeva, G., Lukasheva, E. V., Treshchalin, M. I., Tsurkan, S. A.

“…Introduction. the ability of the small intestine (internalization) to absorb water-soluble anticancer cytostatics determines the possibility of their oral…”
Get full text

Cytostatic-assisted myelosuppression using dicarbamin, an oral hematoprotector (experimental study) by Treshchalin, I D, Bodiagin, D A, Pereverzeva, E R, Treshchalin, M I, Nebol'sin, V E

Get more information

Toxicological Evaluation of Intravenous Formulation of Rifapentine by K. P. Ostrovskiy, E. R. Pereverzeva, I. D. Treshchalin, N. S. Osipova, M. I. Treshchalin, E. V. Voznyakovskaya, V. Yu. Balabanyan, O. O. Maksimenko, S. E. Gelperina

“…Rifapentine belongs to the most potent antituberculosis drugs. Nevertheless, there are some limitations for its clinical use because of the low aqueous…”
Get full text

Hematological toxicity of some combined chemotherapy schemes involving aranoza by Pokrovskiĭ, V S, Treshchalin, M I, Bodiagin, D A, Treshchalina, E M

“…Hematological toxicity of four combined chemotherapy schemes--TAr, TPAr, EPAr, and IPAr--involving aranose (Ar), cisplatin (P), etoposide (E), irinotecan (I),…”
Get more information